These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4144672)

  • 1. Duration of action of beta-blocking drugs.
    Carruthers SG; Kelly JG; McDevitt DG; Shanks RG; Walsh MJ
    Br Med J; 1973 Apr; 2(5859):177. PubMed ID: 4144672
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of beta-blocking agents.
    Goldstein RE
    Circulation; 1973 Mar; 47(3):443-5. PubMed ID: 4144218
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of beta blockade with serum practolol levels after oral administration.
    Schneck DW; Aoki VS; Kroetz FW; Wilson WR
    Clin Pharmacol Ther; 1972; 13(5):685-93. PubMed ID: 4403358
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of relative actions of beta-adrenergic blocking drugs on heart rate and left ventricular ejection using a non-invasive method in patients with aortic Starr-Edwards prostheses.
    Crouchman MR
    Br Heart J; 1973 May; 35(5):475-9. PubMed ID: 4146054
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of chronotropic and inotropic effects of different beta adrenolytic drugs].
    Cheymol G; Mouillé P; Laubie M; Schmitt H
    C R Seances Soc Biol Fil; 1972; 166(6):823-8. PubMed ID: 4143908
    [No Abstract]   [Full Text] [Related]  

  • 8. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
    Prichard BN; Aellig WH; Richardson GA
    Postgrad Med J; 1970 Nov; ():Suppl:77-85. PubMed ID: 4395464
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.
    Ablad B; Carlsson E; Ek L
    Life Sci I; 1973 Feb; 12(3):107-19. PubMed ID: 4144510
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 11. Duration of action of beta-blocking drugs.
    Br Med J; 1973 Jun; 2(5868):715. PubMed ID: 4147415
    [No Abstract]   [Full Text] [Related]  

  • 12. [Basis for the use of beta-receptor blockaders in the practice].
    Blankart R
    Schweiz Rundsch Med Prax; 1973 Aug; 62(32):975-8. PubMed ID: 4147247
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade.
    Prys-Roberts C; Foëx P; Biro GP; Roberts JG
    Br J Anaesth; 1973 Jul; 45(7):671-81. PubMed ID: 4147153
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.
    Bodem G; Chidsey CA
    Clin Pharmacol Ther; 1973; 14(1):26-9. PubMed ID: 4405104
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of haemodynamic effects of oxprenolol (trasicor), alprenolol (aptin), and sotalol (MJ 1999) in man.
    Gibson DG; Hoy J; Sowton E
    Br Heart J; 1970 Jul; 32(4):553. PubMed ID: 4393535
    [No Abstract]   [Full Text] [Related]  

  • 16. Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.
    Lemmer B; Wiethold G; Hellenbrecht D; Bak IJ; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(3):299-313. PubMed ID: 4143918
    [No Abstract]   [Full Text] [Related]  

  • 17. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats.
    Kleinrok Z; Ksiazek A
    Pol J Pharmacol Pharm; 1975; 27(2):177-82. PubMed ID: 239397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
    Regårdh CG
    Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Jul; 26(13):1201-5. PubMed ID: 4147032
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of intravenous pindolol and propranolol in normal man.
    Hicks DC; Arbab AG; Turner P; Hills M
    J Clin Pharmacol New Drugs; 1972; 12(5):212-6. PubMed ID: 4402370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.